Zobrazeno 1 - 10
of 222
pro vyhledávání: '"Francisco A Kerdel"'
Autor:
Aida Lugo-Somolinos, Francisco A. Kerdel, Amy S. Paller, Michelle Longcore, Errol P. Prens, Alexa B. Kimball, Yinghui Duan, Henrique D. Teixeira
Publikováno v:
American Journal of Clinical Dermatology
American Journal of Clinical Dermatology, 21(4), 579-590. Adis
American Journal of Clinical Dermatology, 21(4), 579-590. Adis
Background Hidradenitis suppurativa (HS), also known as acne inversa, is a recurring, painful, chronic, and sometimes disfiguring inflammatory skin disease. Objectives Our objective was to report the baseline clinical characteristics, natural history
Autor:
Mark Lebwohl, Francisco A. Kerdel, Earl Goehring, Abby Jacobson, Binu Alexander, Craig L. Leonardi, April W. Armstrong, Nicole Rawnsley
Publikováno v:
Dermatologic Therapy. 34
Brodalumab, an interleukin-17 receptor A antagonist, is approved for treatment of moderate-to-severe plaque psoriasis in adults without response or with loss of response to other systemic therapies. In the United States, there is a boxed warning for
Publikováno v:
Mediators of Inflammation, Vol 12, Iss 5, Pp 309-313 (2003)
Background: Psoriatic plaques have been shown to contain increased levels of proinflammatory cytokines. Serum levels of interleukin (IL)-6, IL-7, IL-8, and interferon (IFN)-γ have been reported elevated in psoriatic patients.
Externí odkaz:
https://doaj.org/article/38a28ea30abf428890c95aaac8a040e4
Autor:
Jashin J. Wu, Yin You, Melinda Gooderham, Francisco A. Kerdel, Luis Puig, Yaung-Kaung Shen, Bruce Randazzo
Publikováno v:
JOURNAL OF DERMATOLOGICAL TREATMENT
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Altres ajuts: Janssen Research and Development (JRD) Introduction: In VOYAGE 1 (NCT02207231) and VOYAGE 2 (NCT02207244), guselkumab, an interleukin-23 blocker, was safe and effective in patients with moderate-to-severe plaque psoriasis. Methods: Pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c0d92dd42fede3e4f3fc37a5eecff9f
https://ddd.uab.cat/record/269696
https://ddd.uab.cat/record/269696
Publikováno v:
Scopus-Elsevier
Lichen Planus (LP), the prototype of lichenoid dermatoses, is an idiopathic, T cell-mediated, autoimmune, inflammatory disease. It may affect the skin, hair, nails, and mucous membranes. Many clinical variants of LP have been described, including lic
Publikováno v:
Dermatologic Therapy. 33
Publikováno v:
Dermatologic therapyREFERENCES. 33(6)
Publikováno v:
Expert opinion on emerging drugs. 25(3)
Hidradenitis suppurativa (HS) is a severe, chronic inflammatory disorder that causes recurrent occlusion of hair follicles in the intertriginous regions of the skin. Mild to moderate HS has been successfully treated with oral antibiotics, topical the
Publikováno v:
Journal of Dermatological Treatment. 30:333-339
Background: Halobetasol propionate (HP) 0.05% is a highly effective short-term treatment for plaque psoriasis.Objective: Compare efficacy and safety of once-daily HP 0.01% lotion and 0.05% cream (U...
Publikováno v:
Journal of the American Academy of Dermatology. 83:221-222